Skip to main content


Generation of genetically engineered mice

  • Sophisticated targeting allele design and production
  • ES production and blastocyst injection
  • Transgenic production through pronuclear injection
  • GEMM support technologies

Mouse Phase 1 Unit (MP1U)

Test novel therapeutics using GEMMs in a manner faithful to human cancers

More Information

This core facility is under the direction of faculty directors Bernard Weissman,
PhD, and Norman Sharpless, MD, and facility director Dale Cowley, PhD.